The Nifty Pharma Index is currently trading in a defined range between 23,700 and 22,700. This suggests that the market is experiencing indecision, with neither buyers nor sellers dominating.
The current range provides a predictable pattern for traders, where the optimal strategy would be to buy near the support level of 22,700 and sell near the resistance of 23,700. However, a breakout from this range would bring fresh trading opportunities and directional clarity. If the index closes above 23,700, it would indicate a bullish breakout, leading to the next resistance level at 24,200.
This would likely spark further buying interest, pushing the index higher. On the flip side, if the index closes below 22,700, it would confirm a bearish trend, opening the way for a decline towards the next support levels of 22,250 and 21,800. Until such a breakout occurs, traders may prefer to continue trading within the range.
For risk-averse traders, waiting for a confirmed breakout is a safer strategy. A close above 23,700 would be a signal to go long, while a close below 22,700 would warrant short positions. In both cases, stop-losses should be strategically placed to limit potential losses.
For this reason, a sell-on-rise strategy is recommended, where traders can look to sell near the resistance level of 65,625, with a strict stop-loss placed at this level on a closing basis. If the index closes above 65,625, it would signal a bullish breakout with an upside target of 66,200.
However, given the overbought condition, this scenario seems less likely. Should the index close below 64,264, a bearish breakout would be confirmed, targeting lower supports at 63,800 and 63,000. For range traders, buying near support and selling near resistance is also viable, but caution is advised due to the overbought nature of the index.
Both the Nifty Pharma and Nifty FMCG indices are range-bound, presenting opportunities for range-bound trading strategies. While the Pharma index offers a balanced trading range with defined breakouts, the FMCG index shows overbought conditions, making a sell-on-rise strategy more favorable. Conservative traders should wait for clear breakouts in either direction before committing to trades, ensuring proper risk management through the use of stop-losses.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)